Home › Trials › NCT06455228
Clinical trial No longer in our active list Interventional Ages 18 and up

Using long intravenous catheters for antimicrobial therapy

Official title: Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy: a Randomized Controlled Trial

Run by Sir Run Run Shaw Hospital · NCT06455228 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests whether using long intravenous catheters in different places on the body can make it safer and more comfortable for patients getting long-term antimicrobial treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorSir Run Run Shaw Hospital
Academic / other
Locations1 site (Hangzhou)
Trial IDNCT06455228 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require intravenous antimicrobial therapy for at least one week during hospitalization.

Probably not a fit

Patients with a history of complications at the catheterization site or those planning to be discharged with a catheter may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of long peripheral intravenous catheters (PIVCs) in patients receiving antimicrobial therapy, focusing on the effects of different insertion sites. The goal is to identify the optimal placement site that minimizes complications, extends catheter retention time, and reduces patient discomfort. By comparing outcomes based on various insertion locations, the study aims to provide evidence-based recommendations for clinicians. The research is particularly relevant for patients requiring prolonged intravenous treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved patient comfort and reduced complications associated with long-term intravenous antimicrobial therapy.

How similar studies have gone: While there may be studies on catheter placement, this specific approach focusing on long PIVCs in antimicrobial therapy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure \< 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%.

Exclusion Criteria:

* ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.

Where it's running

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
    Hangzhou, China     Recruiting

Study contacts

  • Principal investigator: Zhao Linfang — Sir Run Run Shaw Hospital
  • Study coordinator: Zhao Linfang
  • Email: 3193159@zju.edu.cn
  • Phone: 13588819123

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Sir Run Run Shaw Hospital 29
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.